A phase II trial of salirasib in patients with stage IIIB/IV lung adenocarcinoma enriched for KRAS mutations Meeting Abstract
| Authors: | Johnson, M. L.; Rizvi, N. A.; Ginsberg, M. S.; Miller, V. A.; Kris, M. G.; Pao, W.; Riely, G. J. |
| Abstract Title: | A phase II trial of salirasib in patients with stage IIIB/IV lung adenocarcinoma enriched for KRAS mutations |
| Meeting Title: | 45th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 27 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2009 May 29-Jun 2 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2009-05-20 |
| Start Page: | 410s |
| Language: | English |
| ACCESSION: | WOS:000276606605215 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2009.27.15_suppl.8012 |
| Notes: | Meeting Abstract: 8012 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
